These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7642288)

  • 1. Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccine.
    Aase A; Bjune G; Høiby EA; Rosenqvist E; Pedersen AK; Michaelsen TE
    Infect Immun; 1995 Sep; 63(9):3531-6. PubMed ID: 7642288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine.
    Naess LM; Aarvak T; Aase A; Oftung F; Høiby EA; Sandin R; Michaelsen TE
    Vaccine; 1999 Feb; 17(7-8):754-64. PubMed ID: 10067680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial.
    Wedege E; Høiby EA; Rosenqvist E; Bjune G
    Infect Immun; 1998 Jul; 66(7):3223-31. PubMed ID: 9632589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection.
    Rosenqvist E; Harthug S; Frøholm LO; Høiby EA; Bøvre K; Zollinger WD
    J Clin Microbiol; 1988 Aug; 26(8):1543-8. PubMed ID: 3139705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine.
    Vermont CL; van Dijken HH; van Limpt CJ; de Groot R; van Alphen L; van Den Dobbelsteen GP
    Infect Immun; 2002 Feb; 70(2):584-90. PubMed ID: 11796586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum opsonins to group B meningococci.
    Sjursen H; Bjerknes R; Halstensen A; Naess A; Frøholm LO; Rosenqvist E; Solberg CO
    Acta Pathol Microbiol Immunol Scand C; 1987 Dec; 95(6):283-9. PubMed ID: 3126623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG subclass antibodies to serogroup B meningococcal outer membrane antigens following infection and vaccination.
    Sjursen H; Wedege E; Rosenqvist E; Naess A; Halstensen A; Matre R; Solberg CO
    APMIS; 1990 Dec; 98(12):1061-9. PubMed ID: 2126441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonophagocytic and bactericidal activity mediated by purified IgG subclass antibodies after vaccination with the Norwegian group B meningococcal vaccine.
    Aase A; Høiby EA; Michaelsen TE
    Scand J Immunol; 1998 Apr; 47(4):388-96. PubMed ID: 9600322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A linear B-cell epitope on the class 3 outer-membrane protein of Neisseria meningitidis recognized after vaccination with the Norwegian group B outer-membrane vesicle vaccine.
    Delvig AA; Wedege E; Caugant DA; Dalseg R; Kolberg J; Achtman M; Rosenqvist E
    Microbiology (Reading); 1995 Jul; 141 ( Pt 7)():1593-600. PubMed ID: 7551027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine-induced IgG antibodies to the linear epitope on the PorB outer membrane protein promote opsonophagocytosis of Neisseria meningitidis by human neutrophils.
    Delvig AA; Michaelsen TE; Aase A; Hoiby EA; Rosenqvist E
    Clin Immunol Immunopathol; 1997 Jul; 84(1):27-35. PubMed ID: 9191881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines.
    Toropainen M; Saarinen L; Wedege E; Bolstad K; Mäkelä PH; Käyhty H
    Vaccine; 2005 Sep; 23(40):4821-33. PubMed ID: 15970361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry.
    Plested JS; Ferry BL; Coull PA; Makepeace K; Lehmann AK; MacKinnon FG; Griffiths HG; Herbert MA; Richards JC; Moxon ER
    Infect Immun; 2001 May; 69(5):3203-13. PubMed ID: 11292742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-cell responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine.
    Naess LM; Oftung F; Aase A; Wetzler LM; Sandin R; Michaelsen TE
    Infect Immun; 1998 Mar; 66(3):959-65. PubMed ID: 9488382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease.
    Aase A; Naess LM; Sandin RH; Herstad TK; Oftung F; Holst J; Haugen IL; Høiby EA; Michaelsen TE
    Vaccine; 2003 May; 21(17-18):2042-51. PubMed ID: 12706694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis.
    Rosenqvist E; Musacchio A; Aase A; Høiby EA; Namork E; Kolberg J; Wedege E; Delvig A; Dalseg R; Michaelsen TE; Tommassen J
    Infect Immun; 1999 Mar; 67(3):1267-76. PubMed ID: 10024570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitidis serogroup C vaccines.
    Sikkema DJ; Friedman KE; Corsaro B; Kimura A; Hildreth SW; Madore DV; Quataert SA
    Clin Diagn Lab Immunol; 2000 Sep; 7(5):764-8. PubMed ID: 10973451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to tetravalent meningococcal vaccine: opsonic and bactericidal functions of normal and properdin deficient sera.
    Söderström C; Braconier JH; Käyhty H; Sjöholm AG; Thuresson B
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):220-4. PubMed ID: 2496990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease.
    Fischer M; Carlone GM; Holst J; Williams D; Stephens DS; Perkins BA
    Vaccine; 1999 May; 17(19):2377-83. PubMed ID: 10392619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison on the levels of human serum antibody against Neisseria meningitidis serogroup C measured using serum bactericidal assay and ELISA].
    Zhu BQ; Xu L; Zhou HJ; Shao ZJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 May; 33(5):521-4. PubMed ID: 22883183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate.
    Fukasawa LO; Gorla MC; Schenkman RP; Garcia LR; Carneiro SM; Raw I; Tanizaki MM
    Vaccine; 1999 Aug; 17(23-24):2951-8. PubMed ID: 10462229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.